|
Oligonucleotide Array Sequence Analysis
|
E05.393.760.640 |
|
|
Platelet Endothelial Cell Adhesion Molecule-1
|
D23.050.301.350.131 |
|
|
Graft vs Host Disease
|
D006086 |
[The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
] |
|
Staphylococcal Skin Infections
|
C17.800.838.765.770 |
|
|
Graft vs Host Reaction
|
D006087 |
[An immunological attack mounted by a graft against the host because of tissue incompatibility when immunologically competent cells are transplanted to an immunologically incompetent host; the resulting clinical picture is that of GRAFT VS HOST DISEASE.
] |
|
Myelin Sheath
|
A08.800.800.690.500 |
|
|
Gram-Negative Aerobic Bacteria
|
D006088 |
[A large group of aerobic bacteria which show up as pink (negative) when treated by the gram-staining method. This is because the cell walls of gram-negative bacteria are low in peptidoglycan and thus have low affinity for violet stain and high affinity for the pink dye safranine.
] |
|
Gram-Negative Anaerobic Bacteria
|
D006089 |
[A large group of anaerobic bacteria which show up as pink (negative) when treated by the Gram-staining method.
] |
|
Health Care Reform
|
N04.590.374.285 |
|
|
Graft Enhancement, Immunologic
|
D006082 |
[The induction of prolonged survival and growth of allografts of either tumors or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunized donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity.
] |
|
Graft Occlusion, Vascular
|
D006083 |
[Obstruction of flow in biological or prosthetic vascular grafts.
] |
|
Graft Rejection
|
D006084 |
[An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient.
] |
|
Tuberculosis, Renal
|
C12.777.419.912 |
|
|
Graft Survival
|
D006085 |
[The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host.
] |
|
Pre-Excitation Syndromes
|
C14.280.067.780 |
|
|
Ovarian Follicle
|
D006080 |
[A degenerating ovarian follicle as a result of atresia (FOLLICULAR ATRESIA). During atresia, the OOCYTE and GRANULOSA CELLS within the basal lamina die and are replaced by fibrous tissue.
, The blister-like mature ovarian follicle containing the OVUM surrounded by an accumulation of GRANULOSA CELLS (the cumulus oophorus) and an increasing volume of FOLLICULAR FLUID. The mature Graafian follicle is ready to release the ovum by the process of OVULATION.
, An OOCYTE-containing structure in the cortex of the OVARY. The oocyte is enclosed by a layer of GRANULOSA CELLS providing a nourishing microenvironment (FOLLICULAR FLUID). The number and size of follicles vary depending on the age and reproductive state of the female. The growing follicles are divided into five stages: primary, secondary, tertiary, Graafian, and atretic. Follicular growth and steroidogenesis depend on the presence of GONADOTROPINS.
] |
|
Flow Cytometry
|
E05.196.712.516.600.240.350 |
|
|
Cholangitis, Sclerosing
|
C06.130.120.200.110 |
|
|
Sparteine
|
D03.132.786 |
|
|
Ethenoadenosine Triphosphate
|
D03.633.100.759.646.138.236.250 |
|
